These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 3457980)
1. Overcoming drug resistance in cancer cells with synthetic isoprenoids. Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980 [TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line. Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102 [TBL] [Abstract][Full Text] [Related]
3. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365 [TBL] [Abstract][Full Text] [Related]
4. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602 [TBL] [Abstract][Full Text] [Related]
5. Acquired vs innate multidrug resistance and the effect of calcium channel blockers. Tsuruo T Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin. Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340 [TBL] [Abstract][Full Text] [Related]
7. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52. Shinoda H; Inaba M; Tsuruo T Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316 [TBL] [Abstract][Full Text] [Related]
8. Techniques to reverse or circumvent drug-resistance in vitro. Kuwano M; Nakagawa M; Shiraishi N; Yamaguchi T; Kikuchi J; Akiyama S Prog Clin Biol Res; 1986; 223():163-71. PubMed ID: 3809198 [TBL] [Abstract][Full Text] [Related]
9. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors]. Tsuruo T Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181 [TBL] [Abstract][Full Text] [Related]
10. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker. Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y Cancer Treat Rep; 1985 May; 69(5):523-5. PubMed ID: 4005874 [TBL] [Abstract][Full Text] [Related]
11. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192 [TBL] [Abstract][Full Text] [Related]
12. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors]. Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824 [TBL] [Abstract][Full Text] [Related]
13. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells. Tomida A; Tatsuta T; Suzuki H Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855 [TBL] [Abstract][Full Text] [Related]
14. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by a novel quinoline derivative, MS-209. Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268 [TBL] [Abstract][Full Text] [Related]
16. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559 [TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives. Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484 [TBL] [Abstract][Full Text] [Related]
18. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells. Breier A; Drobná Z; BarancĂk M Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669 [TBL] [Abstract][Full Text] [Related]
19. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin]. Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia. Tsuruo T; Oh-Hara T; Sudo Y; Naito M Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]